 |
||||||||
 |
||||||||
| Dr. Narain Naidu has led a world-wide team of scientists and technicians to develop a Noble Peace Prize nominated technology called bio-replenishment. Dr. Naidu is responsible for the development of OsteoDenx formula, the first breakthrough technology in the area of bio-replenishment. OsteoDenx is a natural supplement, clinically proven to enhance bone density with no side effects. | ||||||||
|
||||||||
| An estimated 10 million Americans over the age of 50 have Osteoporosis. Another 34 million have low bone mass. Approximately 1.5 million Americans suffer fractures due to weak bones. Half of all women over age 50 will have an osteoporosis-related fracture. The aging phenomenon and its potential impact on bone disease are not unique to the United States. Across the globe, the number of individuals age 65 and older is expected to increase nearly five-fold between 1990 and 2050, from 323 million to 1.55 billion. Increasing the number of hip fractures worldwide, from an estimated 1.7 million in 1990 to a projected 6.3 million in 2050. | ||||||||
 |
||||||||
